| 000 | 02703 a2200793 4500 | ||
|---|---|---|---|
| 005 | 20250516123055.0 | ||
| 264 | 0 | _c20130502 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1096-9896 | ||
| 024 | 7 |
_a10.1002/path.4151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVilla, Luigi | |
| 245 | 0 | 0 |
_aLate angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms. _h[electronic resource] |
| 260 |
_bThe Journal of pathology _cApr 2013 |
||
| 300 |
_a672-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAtenolol _xpharmacology |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzoates _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCell Dedifferentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aChemokine CCL20 _xgenetics |
| 650 | 0 | 4 | _aCytoprotection |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGlomerular Mesangium _xdrug effects |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xpharmacology |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xpharmacology |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aIsoantibodies |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aPodocytes _xdrug effects |
| 650 | 0 | 4 |
_aProteinuria _xdrug therapy |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, CCR6 _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Platelet-Derived Growth Factor _xdrug effects |
| 650 | 0 | 4 | _aTelmisartan |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aBoor, Peter | |
| 700 | 1 | _aKonieczny, Andrzej | |
| 700 | 1 | _aKunter, Uta | |
| 700 | 1 | _avan Roeyen, Claudia R C | |
| 700 | 1 | _aDenecke, Bernd | |
| 700 | 1 | _aGan, Lin | |
| 700 | 1 | _aNeusser, Matthias A | |
| 700 | 1 | _aCohen, Clemens D | |
| 700 | 1 | _aEitner, Frank | |
| 700 | 1 | _aScholl, Thomas | |
| 700 | 1 | _aOstendorf, Tammo | |
| 700 | 1 | _aFloege, Jürgen | |
| 773 | 0 |
_tThe Journal of pathology _gvol. 229 _gno. 5 _gp. 672-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.4151 _zAvailable from publisher's website |
| 999 |
_c22301263 _d22301263 |
||